A team of researchers, led by Peter Mac’s Prof Rod Hicks, has been awarded a $1.5 million grant from the US-based Neuroendocrine Tumour Research Foundation (NETRF) to study new treatment approaches for this rare and difficult to treat cancer.
The new study will build on previous work into the use of drugs to sensitive cancers to PRRT, established by Prof Rod Hicks, Peter Mac’s Director of the Centre for Cancer Imaging, Head of the Molecular Imaging and Targeted Therapeutic Laboratory and Co-Chair of the Neuroendocrine Service, and Dr Shahneen Sandhu, clinician researcher and Medical Oncologist at Peter Mac.
